Innovative business and academic projects from across the UK’s health sector will benefit from a new £93.2 million package of support announced yesterday by Universities and Science Minister David Willetts.
The investment includes £25.9 million from Round 3 of the Biomedical Catalyst. 29 companies and five universities will receive investment from the Catalyst. Projects include clinical trials to ‘repurpose’ a cancer drug that could be used to treat rheumatoid arthritis (RA) and an implant to reduce pain and restore mobility to knee cartilage injuries. As…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
